Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Patient Tracking Report—Wave 1

April 2, 2020

Wave 2 of this Tracking Report is now available here!

With the recent outbreak of the novel coronavirus (COVID-19) in the US, InCrowd wanted to understand how patients with chronic conditions and those who are immunocompromised have been impacted by the virus, and how they anticipate ways in which their lives and disease management will be affected moving forward.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

  • Method: 9-minute MicroSurvey via InCrowd & Rare Patient Voice
  • Crowds: Patients with Mild to Severe Illness
  • Sample Size: n=152 (77 Mild to Moderate Patients, 75 Moderate to Severe Patients)
  • Fielding Period: March 25-26, 2020

InCrowd’s other COVID-19 Tracking Reports:

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.